Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in Advanced Cutaneous Squamous Cell Carcinoma
NCT00240682Phase 2Completed
- Sponsor
- Centre hospitalier de Chartres
- Start
- Oct 2005
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in cutaneous squamous cell carcinoma (cSCC), sponsored by Centre hospitalier de Chartres. Started Oct 2005; status: completed.
02
Drugs
KL-140
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT00240682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240682.